KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 126 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q1 2015. The put-call ratio across all filers is 1.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $4,614,000 | – | 92,000 | – | 0.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 1,810,518 | $71,986,000 | 2.98% |
Redmile Group, LLC | 443,326 | $17,627,000 | 2.10% |
AlpInvest Partners B.V. | 22,224 | $884,000 | 2.04% |
SENZAR ASSET MANAGEMENT, LLC | 89,500 | $3,558,000 | 1.88% |
Aureus Asset Management, LLC | 136,305 | $5,419,000 | 1.39% |
PFM Health Sciences, LP | 1,003,492 | $39,899,000 | 0.72% |
REGENTATLANTIC CAPITAL LLC | 176,454 | $7,016,000 | 0.68% |
Ghost Tree Capital, LLC | 25,000 | $994,000 | 0.59% |
HAMILTON LANE ADVISORS LLC | 30,264 | $1,203,000 | 0.48% |
Pentwater Capital Management LP | 390,000 | $15,506,000 | 0.41% |